)
Visual
test
Livzon Pharmaceutical
Livzon Pharmaceutical (000513) investor relations material
Livzon Pharmaceutical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary24 Mar, 2026
Executive summary
Achieved revenue of RMB 12.02 billion in 2025, up 1.76% year-over-year; net profit attributable to shareholders was RMB 2.02 billion, down 1.84% year-over-year; adjusted net profit (excluding non-recurring items) grew 1.51% year-over-year.
R&D investment reached RMB 1.06 billion, accounting for 8.79% of revenue; 40 projects in pipeline, with 12 in registration, 4 in phase III, and 6 in phase II.
Overseas revenue rose 11.97% year-over-year, accounting for 16.06% of total revenue.
Major product launches and regulatory approvals in digestive, reproductive, CNS, and autoimmune fields.
Financial highlights
Revenue: RMB 12.02 billion (+1.76% YoY); net profit attributable to shareholders: RMB 2.02 billion (-1.84% YoY); adjusted net profit: RMB 2.01 billion (+1.51% YoY).
Operating cash flow: RMB 3.15 billion (+5.58% YoY); total assets: RMB 23.99 billion (-1.92% YoY); net assets: RMB 13.89 billion (+0.19% YoY).
Basic/diluted EPS: RMB 2.27 (+1.34% YoY); gross margin for chemical drugs: 81.06%.
R&D capitalization rate increased to 13.67%.
Outlook and guidance
2026 focus: innovation-driven growth, global expansion, digital transformation, and quality management.
Continued investment in AI-enabled R&D, expansion in digestive, reproductive, CNS, and chronic disease areas.
Overseas business to further increase as a share of revenue; ongoing integration of Vietnam IMP acquisition.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Livzon Pharmaceutical
- Net profit grew 5.5% to RMB 2.06B despite a 4.97% revenue drop, with higher dividend proposed.000513
Q4 202426 Dec 2025 - Net profit rose 4.44% year-over-year to RMB 1.67 billion, despite a 5.94% revenue drop.000513Q3 202426 Dec 2025
- Net profit grew 3.21% to RMB 1.17 billion despite a 6.09% revenue decline.000513Q2 202426 Dec 2025
- Net profit up 4.75% year-over-year, revenue down 1.92%, with major share buybacks.000513Q1 202526 Dec 2025
- Q3 2025 saw modest revenue growth, a dip in net profit, and robust operating cash flow.000513Q3 202523 Oct 2025
- Net profit rose 9.40% to RMB 1.28 billion on stable revenue and strong overseas growth.000513Q2 202520 Aug 2025
Livzon Pharmaceutical
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage